Search results
27 paź 2014 · At doses averaging 3.2 ± 1.3 mg, prazosin simultaneously reduced subjective stress and improved cognitive performance over the placebo condition, suggesting that alpha 1 adrenergic blockade improved PFC function in PTSD individuals under duress (Taylor et al., 2006).
5 maj 2020 · Our results demonstrated that prazosin might alleviate defensive behaviors and traumatic stress symptoms when given during the traumatic cue presentation in the stressed rats. However prazosin administration resulted in higher anxiety levels in non stressed rats when the neutral cue was presented. Conclusion.
14 maj 2021 · Prazosin decreases the effects of norepinephrine on brain alpha-1 adrenoreceptors and may be a promising agent for the treatment of PTSD, as some studies found it to be effective and well tolerated. A study examined the role of the noradrenergic system in the pathophysiology of PTSD and conducted a systematic review to evaluate the efficacy and ...
6 maj 2015 · The α-1 adrenoreceptor antagonist prazosin decreases noradrenaline effects at brain α-1 adrenoreceptors and may be a promising agent in the treatment of PTSD, as some studies have found it...
Background: Prazosin has been an accepted treatment for patients with post-traumatic stress disorder (PTSD) who experience sleep disturbances, including nightmares. Results of a recent large randomized control trial did not find benefit of prazosin vs placebo in improving such outcomes.
7 kwi 2015 · The contribution of increased CNS noradrenergic activity to PTSD pathophysiology and the involvement of the postsynaptic alpha-1 adrenoreceptor in brain systems relevant to PTSD symptomatology provide neurobiologic rationale for prazosin as a PTSD pharmacotherapeutic.
14 maj 2021 · Prazosin improved not only depression symptoms but also sleep quality, suicidal ideation, and cognitive function. Prazosin was well tolerated without obvious adverse effects.
